Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto de Castro

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Discovery Medicine|September 1, 2015
Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patientsThomás Giollo Rivelli, Milena Perez Mak, Renata Eiras Martins, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspectiveJonas A de Souza, Iuri A Santana, Gilberto de Castro, et al.
Ecancermedicalscience|April 18, 2018
Cystic brain metastases in ALK-rearranged non-small cell lung cancerGuilherme Nader Marta, Renata Rodrigues da Cunha Colombo Bonadio, Renata Eiras Martins, et al.
JTO Clinical and Research Reports|December 4, 2023
Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review With Meta-AnalysisGilberto de Castro, Fabiano Hahn Souza, Júlia Lima, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2021
Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscapeFabiano de Almeida Costa, Mariane Tami Amano, Paula Fontes Asprino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2016
Responses to Crizotinib Can Occur in High-Level MET-Amplified Non-Small Cell Lung Cancer Independent of MET Exon 14 AlterationsRafael Caparica, Cheng Tzu Yen, Renata Coudry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Overcoming Primary and Acquired Resistance to Immunotherapy in Non-Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging StrategiesCassio Murilo Hidalgo-Filho, Valentina Santo, Eleonora Gariazzo, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersMateus Trinconi Cunha, Vinicius Jardim Carvalho, Rafael Maffei Loureiro, et al.
Ecancermedicalscience|January 11, 2020
Successful osimertinib rechallenge following drug-induced pneumonitis after previous anti-PDL1 exposureGuilherme Harada, Fernando Costa Santini, Felipe Sales Nogueira Amorim Canedo, et al.
Lung Cancer Management|January 19, 2024
Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studiesFabrício T Garramona, Telma F Cunha, Janaína S Vieira, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Discovery Medicine|September 1, 2015
Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patientsThomás Giollo Rivelli, Milena Perez Mak, Renata Eiras Martins, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspectiveJonas A de Souza, Iuri A Santana, Gilberto de Castro, et al.
Ecancermedicalscience|April 18, 2018
Cystic brain metastases in ALK-rearranged non-small cell lung cancerGuilherme Nader Marta, Renata Rodrigues da Cunha Colombo Bonadio, Renata Eiras Martins, et al.
JTO Clinical and Research Reports|December 4, 2023
Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review With Meta-AnalysisGilberto de Castro, Fabiano Hahn Souza, Júlia Lima, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2021
Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscapeFabiano de Almeida Costa, Mariane Tami Amano, Paula Fontes Asprino, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2016
Responses to Crizotinib Can Occur in High-Level MET-Amplified Non-Small Cell Lung Cancer Independent of MET Exon 14 AlterationsRafael Caparica, Cheng Tzu Yen, Renata Coudry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Overcoming Primary and Acquired Resistance to Immunotherapy in Non-Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging StrategiesCassio Murilo Hidalgo-Filho, Valentina Santo, Eleonora Gariazzo, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersMateus Trinconi Cunha, Vinicius Jardim Carvalho, Rafael Maffei Loureiro, et al.
Ecancermedicalscience|January 11, 2020
Successful osimertinib rechallenge following drug-induced pneumonitis after previous anti-PDL1 exposureGuilherme Harada, Fernando Costa Santini, Felipe Sales Nogueira Amorim Canedo, et al.
Lung Cancer Management|January 19, 2024
Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studiesFabrício T Garramona, Telma F Cunha, Janaína S Vieira, et al.
Pageof 16